Peter Bojko

1.4k total citations
37 papers, 523 citations indexed

About

Peter Bojko is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Bojko has authored 37 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Bojko's work include Hematopoietic Stem Cell Transplantation (14 papers), Neutropenia and Cancer Infections (5 papers) and Cancer survivorship and care (5 papers). Peter Bojko is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Neutropenia and Cancer Infections (5 papers) and Cancer survivorship and care (5 papers). Peter Bojko collaborates with scholars based in Germany, United States and Estonia. Peter Bojko's co-authors include S. Seeber, Norbert Mülleneisen, N. Niederle, Tassilo Moritz, J. Hense, M. E. Scheulen, A. Harstrick, Ralf A. Hilger, M. R. Nowrousian and C. Oberhoff and has published in prestigious journals such as Cancer, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Peter Bojko

34 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bojko Germany 13 265 181 92 86 76 37 523
Ming‐Chih Chang Taiwan 11 151 0.6× 91 0.5× 97 1.1× 57 0.7× 147 1.9× 31 373
R Fleischmann United States 8 187 0.7× 54 0.3× 90 1.0× 213 2.5× 79 1.0× 29 674
Umut Dişel Türkiye 13 112 0.4× 152 0.8× 156 1.7× 63 0.7× 56 0.7× 47 478
Hassan El‐Solh Saudi Arabia 15 169 0.6× 226 1.2× 261 2.8× 86 1.0× 97 1.3× 40 693
Marion Sternbach Canada 10 263 1.0× 126 0.7× 126 1.4× 138 1.6× 98 1.3× 17 529
Jeffry B. Lawrence United States 10 146 0.6× 58 0.3× 49 0.5× 148 1.7× 50 0.7× 15 468
Nicole A. Carreau United States 9 410 1.5× 159 0.9× 157 1.7× 73 0.8× 150 2.0× 12 677
G. Salerno Italy 13 119 0.4× 197 1.1× 78 0.8× 47 0.5× 28 0.4× 20 552
Scott Marshall United Kingdom 11 141 0.5× 135 0.7× 73 0.8× 161 1.9× 84 1.1× 32 468
Anand P. Jillella United States 15 485 1.8× 280 1.5× 314 3.4× 79 0.9× 222 2.9× 55 866

Countries citing papers authored by Peter Bojko

Since Specialization
Citations

This map shows the geographic impact of Peter Bojko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bojko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bojko more than expected).

Fields of papers citing papers by Peter Bojko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bojko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bojko. The network helps show where Peter Bojko may publish in the future.

Co-authorship network of co-authors of Peter Bojko

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bojko. A scholar is included among the top collaborators of Peter Bojko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bojko. Peter Bojko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Schmohl, Joerg Uwe, Marcus Hentrich, Peter Bojko, et al.. (2024). Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients’ Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays. International Journal of Molecular Sciences. 25(13). 6983–6983. 4 indexed citations
4.
Stemmler, Hans‐Joachim, Fabian Hauck, Hendrik Schulze‐Koops, et al.. (2022). sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study. Blood Advances. 7(5). 832–844. 11 indexed citations
5.
Bojko, Peter, et al.. (2022). Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes. International Journal of Molecular Sciences. 24(1). 463–463. 7 indexed citations
6.
Bojko, Peter, Wolfgang Abenhardt, Susanne Schnittger, & Torsten Haferlach. (2009). Mutations in the <i>JAK2</i> and <i>MPL</i> Genes and their Correlation to Clinical Parameters in Patients with Chronic Myeloproliferative Disease. Oncology Research and Treatment. 32(4). 191–195. 3 indexed citations
7.
Bojko, Peter, et al.. (2004). Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Annals of Hematology. 84(2). 110–114. 46 indexed citations
8.
Bojko, Peter, Anja Welt, Regina Schleucher, et al.. (2004). High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer. Bone Marrow Transplantation. 34(7). 637–643. 10 indexed citations
9.
Bojko, Peter, et al.. (2003). Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation. Bone Marrow Transplantation. 31(11). 995–1000. 2 indexed citations
11.
Nowrousian, Mohammad R., Peter Bojko, Anja Welt, et al.. (2003). Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients. Annals of Oncology. 14. i29–i36. 30 indexed citations
13.
Bauer, Sebastian, et al.. (2002). Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function. Anti-Cancer Drugs. 13(8). 847–849. 16 indexed citations
14.
Kasimir‐Bauer, Sabine, et al.. (2001). Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy.. PubMed. 7(6). 1582–9. 30 indexed citations
15.
Bojko, Peter, M. E. Scheulen, Ralf A. Hilger, et al.. (2001). High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer. Journal of Cancer Research and Clinical Oncology. 127(4). 243–250. 8 indexed citations
16.
17.
Bojko, Peter, et al.. (1999). Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral blood stem cells. Journal of Clinical Apheresis. 14(2). 57–62. 2 indexed citations
18.
Bojko, Peter, Jeane P. Hester, April Durett, et al.. (1998). Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors. Journal of Clinical Apheresis. 13(1). 7–15. 9 indexed citations
20.
Mülleneisen, Norbert, et al.. (1993). Hypersensitivity reactions to carboplatin. European Journal of Cancer. 29. S208–S208. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026